Clinical inertia in general practice: Widespread and related to the outcome of diabetes care

Family Practice

Volumn 26, Issue 6, 2009, Pages 428-436

  van Bruggen, Rykel ^a   Gorter, Kees ^a   Stolk, Ronald ^b   Klungel, Olaf ^c   Rutten, Guy ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL INERTIA; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSING CARE; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT FAILURE; TREATMENT RESPONSE;

AGED; DIABETES MELLITUS; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS;

EID: 70450181251     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmp053     Document Type: Article

References (36)

1. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Br Med J 1998; 317: 703-713.
2. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-865.
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
4. Colhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-696.
5. Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet 2003; 361: 2005-2016.
6. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
7. Standards of medical care in diabetes - 2006. Diabetes Care 2006; 29 (suppl 1): S4-S42.
8. Bouma M, Rutten GE, de Grauw WJ, Wiersma T, Goudswaard AN. [Summary of the practice guideline 'Diabetes mellitus type 2' (second revision) from the Dutch College of General Practitioners]. Ned Tijdschr Geneeskd 2006; 150: 2251-2256.
9. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations. Lancet 1993; 342: 1317-1322.
10. Detournay B, Cros S, Charbonnel B et al. Managing type 2 diabetes in France: The ECODIA survey. Diabetes Metab 2000; 26: 363-369.
11. Grant RW, Buse JB, Meigs JB. Quality of diabetes care in U.S. academic medical centers: Low rates of medical regimen change. Diabetes Care 2005; 28: 337-442.
12. Khunti K, Baker R, Rumsey M, Lakhani M. Quality of care of patients with diabetes: Collation of data from multi-practice audits of diabetes in primary care. Fam Pract 1999; 16: 54-59.
13. Van Loon H, Deturck L, Buntinx F et al. Quality of life and effectiveness of diabetes care in three different settings in Leuven. Fam Pract 2000; 17: 167-172.
14. Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Clinical inertia in response to inadequate glycemic control: Do specialists differ from primary care physicians? Diabetes Care 2005; 28: 600-606.
15. Phillips LS, Branch WT, Cook CB et al. Clinical inertia. Ann Intern Med 2001; 135: 825-834.
16. O'Connor PJ. Commentary - improving diabetes care by combating clinical inertia. Health Serv Res 2005; 40: 1854-1861.
17. van Bruggen R, Gorter KJ, Stolk RP, Verhoeven RP, Rutten GE. Implementation of locally adapted guidelines on type 2 diabetes. Fam Pract 2008.
18. Rutten GEHM, Verhoeven S, Heine RJ et al. Diabetes mellitus type 2. NHG-standaard (eerste herziening). Huisarts Wet 1999; 42: 67-84.
19. Little RJA. Regression with missing X's: A review. J Am Stat Assoc 1992; 87: 1227-1237.
20. Bruggen van J, Gorter K, Stolk R, Rutten G. Sharing and delegation are not panaceas for improved diabetes care. Huisarts Wet 2006; 49 598-605.
21. Berlowitz DR, Ash AS, Glickman M et al. Developing a quality measure for clinical inertia in diabetes care. Health Serv Res 2005; 40: 1836-1853.
22. Grant RW, Cagliero E, Dubey AK et al. Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med 2004; 21: 150-155.
23. Rodondi N, Peng T, Karter AJ et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med 2006; 144: 475-484.
24. Ab E, Denig P, van Vliet T, Dekker JH. Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study. BMC Fam Pract 2009; 10: 24.
25. Grol R. Improving the quality of medical care: Building bridges among professional pride, payer profit, and patient satisfaction. J Am Med Assoc 2001; 286: 2578-2585.
26. Kassirer JP. The quality of care and the quality of measuring it. N Engl J Med 1993; 329: 1263-1265.
27. Hicks PC, Westfall JM, Van Vorst RF et al. Action or inaction? Decision making in patients with diabetes and elevated blood pressure in primary care. Diabetes Care 2006; 29: 2580-2585.
28. Ziemer DC, Miller CD, Rhee MK et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ 2005; 31: 564-571.
29. WHO Adherence to Long Term Therapies Project. Adherence to Long-term Therapies: Evidence for Action. Geneva: World Health Organization, 2003.
30. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004; 27: 2149-2153.
31. Parris ES, Lawrence DB, Mohn LA, Long LB. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care 2005; 28: 595-599.
32. Pladevall M, Williams LK, Potts LA et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004; 27: 2800-2805.
33. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002; 25: 1015-1021.
34. Bruggen van J, Gorter K, Stolk RP et al. Refill adherence and polypharmacy among patients with type diabetes in general practice. PharmacoepidemiolDrug Saf 2009 July 21 [Epub ahead of print].
35. Cramer JA. Asystematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218-1224.
36. Hsu J, Price M, Huang J et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med 2006; 354: 2349-2359.